BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1348450)

  • 1. Molecular analysis of the chromosome 11p region in renal cell carcinomas.
    Kovacs G; Kiechle-Schwarz M; Scherer G; Kung HF
    Cell Mol Biol; 1992 Feb; 38(1):59-62. PubMed ID: 1348450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential loss of maternal alleles in sporadic Wilms' tumour.
    Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
    Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mosaicism in normal tissues of Wilms' tumour patients.
    Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
    Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.
    Kovacs A; Storkel S; Thoenes W; Kovacs G
    J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiating genetic events in small renal neoplasms detected by comparative genomic hybridization.
    Presti JC; Moch H; Gelb AB; Huynh D; Waldman FM
    J Urol; 1998 Oct; 160(4):1557-61. PubMed ID: 9751412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
    Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.
    Zbar B; Brauch H; Talmadge C; Linehan M
    Nature; 1987 Jun 25-Jul 1; 327(6124):721-4. PubMed ID: 2885753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor.
    Dao DD; Schroeder WT; Chao LY; Kikuchi H; Strong LC; Riccardi VM; Pathak S; Nichols WW; Lewis WH; Saunders GF
    Am J Hum Genet; 1987 Aug; 41(2):202-17. PubMed ID: 3039839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
    Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors.
    Schroeder WT; Chao LY; Dao DD; Strong LC; Pathak S; Riccardi V; Lewis WH; Saunders GF
    Am J Hum Genet; 1987 May; 40(5):413-20. PubMed ID: 2883892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.